ArticleTransplantation direct2025
The Value of Chest and Abdominal CT Scans in Deceased Organ Donor Screening: A Prospective Nationwide Cohort Study.
Article in Transplantation direct, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Standard computed tomography (CT) scanning in deceased organ donor screening may offer advantages over conventional chest radiograph and abdominal ultrasound. Methods: A nationwide prospective cohort study in the Netherlands was conducted, including all deceased organ donors between July 2022 and April 2024. There were 2 groups: those who received standard chest and abdominal CT scan (study group, n = 330) with a new standardized scan protocol and those screened according to the current protocol (chest radiograph and abdominal ultrasound, n = 224, or chest or abdominal CT scan already performed in the clinical workup, n = 162, together the control group, n = 386). Outcomes included the detection of suspicious lesions during screening or procurement, the incidence of procurement-related injuries, explantation time, and transplant outcomes. Results: During screening, suspicious lesions were identified in 19 donors (5.8%) in the study group and in 2 donors (0.5%) in the control group ( Conclusions: In conclusion, CT scanning improves deceased donor screening by reducing unexpected findings during procurement, thereby lowering the risk of procurement-related kidney graft injuries and shortening explantation times.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.